Rising Kenyan star Anyango fails doping test
Athletics
By
AFP
| Oct 05, 2024
Kenya's Emmaculate Anyango, the world's second fastest woman over 10km, has been provisionally suspended after a failed doping test, the Athletics Integrity Unit (AIU) said on Friday.
The 24-year-old Anyango faces a ban of up to four years after testing positive for prohibited testosterone and the banned blood-boosting hormone EPO.
An African U20 3,000m silver medallist in 2019, Anyango has been tipped as one of the East African nation's rising stars.
She became the second Kenyan woman to run 10km in under 29 minutes, finishing runner-up in Valencia in January behind compatriot Agnes Jebet Ngetich who won with a world record 28:46.
Anyango also defied a strong field that included former New York and London marathon champion Joyciline Jepkosgei to win the women's cross-country race at Sirikwa Classic, a World Athletics Tour Gold meeting in Kenya's northwest in February.
READ MORE
Treasury goes for UAE loan as IMF cautions of debt situation
Traders claim closure of liquor stores, bars near schools punitive
Adani fallout is a lesson on accountability and transparency fight
Sustainable finance in focus for Kenyan banks as Co-op Bank feted
Inside battle for control of Bamburi Cement
What forcing Google to sell Chrome could mean
How talent development is shaping Kenya's tech future
Street-style snappers reclaim the heart of Nairobi
Huawei, charity partners to empower women with digital skills in Kenya
African ministers champion ICT adoption for sustainable growth
Kenya has invested massively in the wake of a doping scandal at the 2016 Rio Olympics, creating its revamped anti-doping agency that year. Some 78 athletes have been sanctioned in the last three years alone.
In June Kenya's 10km road race men's record holder Rhonex Kipruto was banned for six years for doping and his world mark cancelled by the AIU.
However, there are fears the programme could be undermined after the Anti-Doping Agency of Kenya said last month that severe budget cuts had halted tests.